Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Contact
Contact
Nexmmune, Inc.
Portfolio
NexImmune Announces Pricing of Upsized Initial Public Offering
By
February 11, 2021
March 9th, 2021
No Comments
NexImmune Inc.
NexImmune Announces Pricing of Upsized Initial Public Offering
February 11, 2021
Previous Post
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
Next Post
Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin
